The researchers analyzed whole blood samples from 164 children newly diagnosed with Crohn’s disease, as well as the blood from 74 control patients.
Here’s what you need to know:
1. Fifty-four of the Crohn’s patients showed disease progression within 36 months of their diagnosis.
2. The researchers identified 1,043 CpGs that significantly correlated with susceptibility to Crohn’s disease.
3. Of the CpGs the researchers identified, 142 also correlated to Crohn’s disease progression.
4. “Recent advances in our understanding of IBD-associated DNA methylation underlie many promising clinical applications such as molecular biomarkers for diagnosis and prognosis of the disease as well as prediction of treatment outcomes,” the researchers concluded. “Even if the results from different studies are encouraging, limitations have thus far prevented widespread clinical application.”
More articles on gastroenterology:
3 new GI-driven ASCs and facilities — June 2018
Dietitians add value to GI practices, ‘Journal of Neurogastroenterology and Motility’ study finds
GI leader to know: Dr. Kent Katz of Gastroenterology Associates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
